Aldosterone antagonism in diastolic heart failure.
Phase of Trial: Phase IV
Latest Information Update: 07 Aug 2018
At a glance
- Drugs Eplerenone (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 07 Sep 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 03 Jun 2008 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.